Harm Jan Bogaard Department of Pulmonary Diseases, Amsterdam UMC VU University Medical Center, Amsterdam Cardiovascular Sciences (ACS) Biography Publications Institution JoVE Articles Harm Jan Bogaard has not added a biography. If you are Harm Jan Bogaard and would like to personalize this page please email our Author Liaison for assistance. Publications Correspondence Regarding "T-box Protein 4 Mutation Causing Pulmonary Arterial Hypertension and Lung Disease": a Single-centre Case Series The European Respiratory Journal. May, 2020 | Pubmed ID: 32409423 Persistent Exercise Intolerance After Pulmonary Endarterectomy for CTEPH The European Respiratory Journal. May, 2020 | Pubmed ID: 32366481 The Effects of Mercaptopurine on Pulmonary Vascular Resistance and BMPR2 Expression in Pulmonary Arterial Hypertension American Journal of Respiratory and Critical Care Medicine. Apr, 2020 | Pubmed ID: 32275837 Assessment of Right Ventricular Responses to Therapy in Pulmonary Hypertension Drug Discovery Today. Mar, 2014 | Pubmed ID: 24637045 Pulmonary Arterial Hypertension Preceding Idiopathic Pulmonary Fibrosis in a BMPR2 Mutation Positive Patient European Respiratory Review : an Official Journal of the European Respiratory Society. Mar, 2014 | Pubmed ID: 24591673 The Importance of Trabecular Hypertrophy in Right Ventricular Adaptation to Chronic Pressure Overload The International Journal of Cardiovascular Imaging. Feb, 2014 | Pubmed ID: 24306052 Definitions and Diagnosis of Pulmonary Hypertension Journal of the American College of Cardiology. Dec, 2013 | Pubmed ID: 24355641 The Right Ventricle Explains Sex Differences in Survival in Idiopathic Pulmonary Arterial Hypertension Chest. Dec, 2013 | Pubmed ID: 24306900 Risk Factors for Hemoptysis in Idiopathic and Hereditary Pulmonary Arterial Hypertension PloS One. 2013 | Pubmed ID: 24194909 Experimental Models of Right Heart Failure: a Window for Translational Research in Pulmonary Hypertension Seminars in Respiratory and Critical Care Medicine. Oct, 2013 | Pubmed ID: 24037635 Diffusion Capacity and BMPR2 Mutations in Pulmonary Arterial Hypertension The European Respiratory Journal. Sep, 2013 | Pubmed ID: 24036241 Pulmonary Arterial Hypertension Combined with a High Cardiac Output State: Three Remarkable Cases Pulmonary Circulation. Apr, 2013 | Pubmed ID: 24015348 Severely Reduced Diffusion Capacity in Idiopathic Pulmonary Arterial Hypertension: Patient Characteristics and Treatment Responses The European Respiratory Journal. Dec, 2013 | Pubmed ID: 23949959 Author's Reply Pulmonary Circulation. Jan, 2013 | Pubmed ID: 23662185 Thyroid Hormone is Highly Permissive in Angioproliferative Pulmonary Hypertension in Rats The European Respiratory Journal. Jan, 2013 | Pubmed ID: 22835607 Cardiopulmonary Exercise Testing Reveals Onset of Disease and Response to Treatment in a Case of Heritable Pulmonary Arterial Hypertension Pulmonary Circulation. Jul, 2012 | Pubmed ID: 23130108 Spirometry in Chronic Obstructive Pulmonary Disease: a Hemodynamic Roller Coaster? American Journal of Respiratory and Critical Care Medicine. Aug, 2012 | Pubmed ID: 22896598 Right Atrial Pressure Affects the Interaction Between Lung Mechanics and Right Ventricular Function in Spontaneously Breathing COPD Patients PloS One. 2012 | Pubmed ID: 22272306 Progressive Changes in Right Ventricular Geometric Shortening and Long-term Survival in Pulmonary Arterial Hypertension Chest. Apr, 2012 | Pubmed ID: 21960697 Progressive Right Ventricular Dysfunction in Patients with Pulmonary Arterial Hypertension Responding to Therapy Journal of the American College of Cardiology. Dec, 2011 | Pubmed ID: 22133851 Diaphragm Muscle Fiber Weakness in Pulmonary Hypertension American Journal of Respiratory and Critical Care Medicine. May, 2011 | Pubmed ID: 21131469 Modèle de maladie microfluidique in vitro pour étudier les interactions endoteléliales du sang entier et la dynamique des caillots sanguins en temps réel Xue D. Manz1, Hugo J. Albers2,3, Petr Symersky4, Jurjan Aman1, Andries D. van der Meer3, Harm Jan Bogaard1, Robert Szulcek1,5,6 1Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam Cardiovascular Sciences (ACS), 2BIOS Lab-on-a-Chip group, University of Twente, 3Applied Stem Cell Technologies Group, University of Twente, 4Department of Cardio-thoracic Surgery, Amsterdam UMC, VU University Medical Center, 5Institute of Physiology, Charité-Universitätsmedizin, 6German Heart Center JoVE 61068 Immunology and Infection Électrique Cell-substrat Impedance Sensing pour la quantification de la prolifération endothéliale, de la fonction barrière, et la motilité Robert Szulcek1, Harm Jan Bogaard1, Geerten P. van Nieuw Amerongen2 1Department of Pulmonary Diseases, Institute for Cardiovascular Research, VU University Medical Center, 2Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center JoVE 51300 Bioengineering
Modèle de maladie microfluidique in vitro pour étudier les interactions endoteléliales du sang entier et la dynamique des caillots sanguins en temps réel Xue D. Manz1, Hugo J. Albers2,3, Petr Symersky4, Jurjan Aman1, Andries D. van der Meer3, Harm Jan Bogaard1, Robert Szulcek1,5,6 1Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam Cardiovascular Sciences (ACS), 2BIOS Lab-on-a-Chip group, University of Twente, 3Applied Stem Cell Technologies Group, University of Twente, 4Department of Cardio-thoracic Surgery, Amsterdam UMC, VU University Medical Center, 5Institute of Physiology, Charité-Universitätsmedizin, 6German Heart Center JoVE 61068 Immunology and Infection
Électrique Cell-substrat Impedance Sensing pour la quantification de la prolifération endothéliale, de la fonction barrière, et la motilité Robert Szulcek1, Harm Jan Bogaard1, Geerten P. van Nieuw Amerongen2 1Department of Pulmonary Diseases, Institute for Cardiovascular Research, VU University Medical Center, 2Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center JoVE 51300 Bioengineering
